Clinical Trials Directory

Trials / Unknown

UnknownNCT02214680

The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Carmel Medical Center · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

In this study we will explore the combined effect of Brimonidine and Timolol 0.5% (Combigan) eye drops on pupil dilation. It is a well studied phenoma that Brimonidine and a miotic effect on the pupil, however the combined effect of alpha agonist and beta blocker has not been studied.

Detailed description

In this study we will explore the combined effect of Brimonidine and Timolol 0.5% (Combigan) eye drops on pupil dilation. It is a well studied phenoma that Brimonidine and a miotic effect on the pupil, however the combined effect of alpha agonist and beta blocker has not been studied. The study subjects will be examined twice, two weeks apart. On the first exam the subject will receive Combigan eye drop to the right eye and a Brimonidine drop to the left eye. The effect on pupil size before and 30 minutes, 60 minutes, 240 minutes, and 300 minutes after instillation of eyedrops. On the second exam the subject will receive Timolol (0.5%) eye drop to the right eye and a Brimonidine drop to the left eye. The effect on pupil size before and 30 minutes, 60 minutes, 240 minutes, and 300 minutes after instillation of eyedrops.

Conditions

Interventions

TypeNameDescription
DRUGCombigan (Combination of Brimonidine and Timolol)On the first exam the subject will receive Combigan (Combination of Brimonidine and Timolol) eye drop to the right eye and a Brimonidine drop to the left eye. The effect on pupil size before and 30 minutes, 60 minutes, 240 minutes, and 300 minutes after instillation of eyedrops. On the second exam the subject will receive Timolol (0.5%) eye drop to the right eye and a Brimonidine drop to the left eye. The effect on pupil size before and 30 minutes, 60 minutes, 240 minutes, and 300 minutes after instillation of eyedrops.
DRUGTimolol0.5% eye drop

Timeline

Start date
2015-10-01
Primary completion
2016-08-01
Completion
2016-12-01
First posted
2014-08-12
Last updated
2015-10-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02214680. Inclusion in this directory is not an endorsement.